Free CME from PeerView


Hematology CME

Credits: 0.75 CME
PVI, PeerView Institute for Medical Education
“Intensity” With Efficacy in Acute Myeloid Leukemia (AML): Developing Modern, Intensive Upfront Platforms for Challenging Disease Presentations
June 21, 2023
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Taking the Leap in MCL: New Opportunities With BTK Inhibitors and Other Innovative Strategies
June 18, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
June 03, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms & Emerging Therapeutics
June 03, 2023
Credits: 2.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
The New ABCs of Myeloma Care: Enhancing Outcomes With CD38 Antibodies, BCMA Immunotherapy, and Unique Bispecific Platforms
June 03, 2023
Credits: 1.5 CME / MOC / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, Multiagent Platforms, and Sequential Strategies
June 02, 2023
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
New Rules for Overcoming ITP: Guidance on Later-Line Care, the Role of BTKi, and Improving Patient Outcomes
June 01, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Building a Foundation for Enhanced Outcomes in Pediatric ALL: Guidance on the Asparaginase Component of Modern Therapy
May 10, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
The Bedrock of Personalized NF1 Care: Fundamentals of Managing NF1-Associated PNs and Other Tumors With Innovative Targeted Therapy
May 09, 2023
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Betting on BCMA in Multiple Myeloma: Oncology Nurse Principles for Delivering Effective Care With BCMA Antibodies and Cellular Therapy
April 27, 2023
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Leading Change, Leading Advances in CLL Care: Guidance on Delivering Modern Targeted and Cellular Therapeutics
April 26, 2023
PVI, PeerView Institute for Medical Education
Coordinating Better Outcomes in Multiple Myeloma: Pharmacist Leadership With Novel Antibodies and CAR-T Therapy
April 13, 2023
PVI, PeerView Institute for Medical Education
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy
March 30, 2023
The Medical College of Wisconsin
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
March 21, 2023
The Medical College of Wisconsin
The Time Is Now for Outpatient CAR-T: Essential Infrastructure, Lessons From Transplant, and New Evidence
March 15, 2023
The Medical College of Wisconsin
The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes
March 13, 2023
The Medical College of Wisconsin
Finding Treatment Synergy in CLL: Expert Consults on Advances With Targeted and Cellular Therapy
March 12, 2023
The Medical College of Wisconsin
New Rules for VOD/SOS: Modern Risk Assessment, Diagnostic Principles, and Innovative Treatment
March 12, 2023
PVI, PeerView Institute for Medical Education
Seizing the Precision Care Moment in MDS: Collaborative Strategies for Accurate Diagnoses and Risk-Adapted Treatment
March 12, 2023
Medical Learning Institute, Inc.
Real-World Challenges and Solutions with BTKi in CLL: Therapeutic Insights for Community Practice
March 05, 2023
PVI, PeerView Institute for Medical Education
Real-World Nursing Solutions for AML Care: Insights on the Effective and Safe Delivery of Innovative Therapeutics
February 27, 2023
The Medical College of Wisconsin
Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options
February 14, 2023
PVI, PeerView Institute for Medical Education
Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options
February 01, 2023
PVI, PeerView Institute for Medical Education
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
February 01, 2023
PVI, PeerView Institute for Medical Education
Changing Times for Hemophilia: Exploring Evidence With Novel and Emerging Nonfactor Therapies
December 29, 2022
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
December 15, 2022

Pages